307 related articles for article (PubMed ID: 31749614)
1. The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.
Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
Int J Chron Obstruct Pulmon Dis; 2019; 14():2409-2421. PubMed ID: 31749614
[TBL] [Abstract][Full Text] [Related]
2. The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization.
Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
J Asthma; 2020 Oct; 57(10):1092-1102. PubMed ID: 31267775
[No Abstract] [Full Text] [Related]
3. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
[TBL] [Abstract][Full Text] [Related]
4. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
5. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
Müllerová H; Hahn B; Simard EP; Mu G; Hatipoğlu U
Int J Chron Obstruct Pulmon Dis; 2019; 14():683-692. PubMed ID: 30962682
[TBL] [Abstract][Full Text] [Related]
6. [Study of the role of blood eosinophil count in patients with severe acute exacerbation of chronic obstructive pulmonary disease hospitalized in a Tunisian Center].
Saad AB; Khemakhem R; Mhamed SC; Fahem N; Migaou A; Joobeur S; Rouatbi N
Pan Afr Med J; 2019; 34():138. PubMed ID: 33708307
[TBL] [Abstract][Full Text] [Related]
7. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
[TBL] [Abstract][Full Text] [Related]
9. Clinical burden of illness among patients with severe eosinophilic COPD.
Müllerová H; Meeraus WH; Galkin DV; Albers FC; Landis SH
Int J Chron Obstruct Pulmon Dis; 2019; 14():741-755. PubMed ID: 31114180
[No Abstract] [Full Text] [Related]
10. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
11. The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care.
Van Rossem I; Vandevoorde J; Hanon S; Deridder S; Vanderhelst E
BMC Pulm Med; 2020 Jul; 20(1):200. PubMed ID: 32698819
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
Lim JU; Kim K; Kim SH; Lee MG; Lee SY; Yoo KH; Lee SH; Jung KS; Rhee CK; Hwang YI
Int J Chron Obstruct Pulmon Dis; 2017; 12():2711-2721. PubMed ID: 28979113
[TBL] [Abstract][Full Text] [Related]
13. COPD symptom burden: impact on health care resource utilization, and work and activity impairment.
Ding B; Small M; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():677-689. PubMed ID: 28260874
[TBL] [Abstract][Full Text] [Related]
14. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
[TBL] [Abstract][Full Text] [Related]
15. Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort.
Trudo F; Kallenbach L; Vasey J; Chung Y; Wilk A; Slipski L; O'Brien D; Strange C
Int J Chron Obstruct Pulmon Dis; 2019; 14():2625-2637. PubMed ID: 32063703
[TBL] [Abstract][Full Text] [Related]
16. Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications.
Lee JH; Rhee CK; Kim K; Kim JA; Kim SH; Yoo KH; Kim WJ; Park YB; Park HY; Jung KS
Int J Chron Obstruct Pulmon Dis; 2017; 12():1135-1144. PubMed ID: 28442900
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a claims-based prediction model for COPD severity.
Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
20. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.
Iheanacho I; Zhang S; King D; Rizzo M; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():439-460. PubMed ID: 32161455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
